Emami expects FY13 topline growth of 16-18% in line with guidance
NH Bhansali, CEO-Finance, Strategy & Business Development at Emami Limited, says the company is aiming for a three-fold increase in sales of its pain relief oinment 'Himani Fast Relief', which was relaunched with a new formulation recently. The FMCG company is expecting to witness topline growth of 16-18 per cent in FY13, in line with its guidance, Bhansali adds.
